GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Type IV Thoracoabdominal Aortic Aneurysms
Completed · Not applicable · NCT02528500
Conditions: Thoracoabdominal Aortic Aneurysm
At a glance
- Research payments reported, 2025
- $1,230
- U.S. investigators named
- 1
- Sites paid
- 1
- Planned or actual enrollment
- 10
About the trial
- Sponsor
- W.L.Gore & Associates
- Tested
- GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (device)
- Dates
- Started 2015-11; completion 2023-02
- Results posted
- Yes
This study will assess the initial feasibility of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE Device) in the treatment of Aortic Aneurysms Involving the Visceral Branch Vessels.
From ClinicalTrials.gov, last updated 2023-06-28. Full record, eligibility and contacts (opens in a new tab)
Industry funding
W. L. Gore & Associates, Inc. reported $1,230 in research payments for this study in 2025 (1 payments).
Products named: Product in Development
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.